影响重型蛛网膜下腔出血结局的因素
该多中心回顾性观察性队列研究分析了日本青森县4家医院收治的329例重型蛛网膜下腔出血患者,按出院时改良Rankin量表评分0-2分为结局良好组41例、3-6分为结局不良组288例。多因素分析显示保守治疗(P<0.001)、Fisher 4级(P<0.007)、年龄≥65岁(P=0.011)及入院时Hunt和Kosnik V级(P=0.021)是结局不良的显著因素。
要点
- 保守治疗、Fisher 4级、年龄≥65岁、Hunt和Kosnik V级与重型SAH结局不良显著相关。
- 非高龄且非V级、非Fisher 4级患者应尽早行动脉瘤治疗,更可能获得良好结局。
- 高龄V级且Fisher 4级患者目前可能难以从动脉瘤治疗中获益。
核心结论
- 非高龄且非V级、非Fisher 4级的重型SAH患者应尽快行动脉瘤治疗,因其更可能获得良好结局。
- 高龄V级且Fisher 4级患者目前可能难以从动脉瘤治疗中获益。
- 开发针对早期脑损伤的治疗可能对改善重型SAH患者结局具有重要意义。
研究设计与样本
- 多中心、回顾性、观察性队列研究,纳入日本青森县4家医院收治的所有自发性蛛网膜下腔出血患者。
- 共纳入329例重型蛛网膜下腔出血患者,出院时改良Rankin量表评分0-2分为结局良好组41例,3-6分为结局不良组288例,比较两组差异。
主要发现
- 结局良好组41例,结局不良组288例。
- 结局多因素分析显示保守治疗(P<0.001)与结局不良显著相关。
- Fisher 4级(P<0.007)与结局不良显著相关。
- 年龄≥65岁(P=0.011)与结局不良显著相关。
- 入院时Hunt和Kosnik V级(P=0.021)与结局不良显著相关。
临床怎么用
- 作者认为,非高龄且非V级、非Fisher 4级的重型SAH患者应尽快行动脉瘤治疗。
- 作者认为,高龄V级且Fisher 4级患者目前可能难以从动脉瘤治疗中获益。
- 作者提出,开发针对早期脑损伤的治疗可能对改善重型SAH患者结局具有重要意义。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Poor-grade subarachnoid hemorrhage (SAH) accounts for 20% of all SAH and is associated with poor outcomes. The first step in improving outcomes is to analyze the factors that contribute to poor outcomes. METHODS: This was a multicenter, retrospective, observational, cohort study. Data fields included demographic, clinical, radiological, and outcome data for all spontaneous patients with SAH treated at 4 hospitals in Aomori Prefecture in Japan. Patients with modified Rankin Scale score 0-2 at discharge were defined as the good outcome group, and those with modified Rankin Scale score 3-6 were defined as the poor outcome group, and comparisons were made between the 2 groups. RESULTS: There were 329 eligible patients with poor-grade SAH, 41 with good outcome group, and 288 with poor outcome group. On multivariate analysis of the outcome, conservative treatment (P < 0.001), Fisher group 4 (P < 0.007), age ≥65 years (P = 0.011), and Hunt and Kosnik grade V on admission (P = 0.021) were significant factors contributing to a poor outcome. CONCLUSIONS: Nonelderly patients who are not in grade V and Fisher group 4 should undergo aneurysm treatment as soon as possible because they are more likely to have a good outcome, whereas elderly patients in grade V and Fisher group 4 are unlikely to benefit from aneurysm treatment at present. The development of a treatment for early brain injury may be important to improve the outcomes of patients with poor-grade SAH.
引用
- Sasaki T, Naraoka M, Shimamura N, et al. Factors Affecting Outcomes of Poor-Grade Subarachnoid Hemorrhage. World Neurosurg. 2024. PMID: 38382759. doi:10.1016/j.wneu.2024.02.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。